India Top 5 In Research Across 50 Critical Technologies. The Harder Part Is Turning That Into Capability.

Every discussion of Indian science and technology follows a familiar script. India's Gross Expenditure on R&D is stuck at 0.64 per cent of GDP. The private sector won't invest. We're falling behind.

The Economic Survey 2025-26 itself repeats this diagnosis, as have previous Surveys, year after year.

But there's another dataset that tells a different story.

The Australian Strategic Policy Institute's Critical Technology Tracker, updated in December 2025, shows that India now ranks among the top five countries in 50 of 74 critical technologies. This is up from 43 technologies in the previous year's update.

In the most recent update, India has overtaken the United States as the second-ranked country in five technologies.

Let that sink in. India — with its 0.64 per cent GERD, its "risk-averse" private sector, its perennial lament about the lab-to-land gap — is now a top-five research power in two-thirds of the technologies that will define the twenty-first century.

What the Tracker Actually Measures

ASPI's Critical Technology Tracker doesn't measure industrial capability or commercial deployment. It measures something more specific and arguably more forward-looking: high-impact research output — the top 10 per cent most-cited papers in each technology field.

This is a leading indicator. Countries that dominate high-impact research today are likely to dominate technological capability tomorrow. It's why China's rise in the tracker over the past two decades — from leading in 3 of 64 technologies in 2003-07 to 66 of 74 today — has set off alarm bells in Washington, Canberra, and Brussels.

India's trajectory, while less dramatic than China's, is striking in its own right. According to ASPI, India is now "emerging as a key centre of global research innovation and excellence, establishing its position as an S&T power."

The data shows India in the top five for technologies spanning:

• Defence and aerospace: third in advanced aircraft engines, autonomous underwater vehicles

• Quantum: third in post-quantum cryptography, fourth in quantum sensors

• Biotechnology: second in biological manufacturing, third in novel antibiotics and antivirals

• AI and communications: second in mesh networks, third in AI algorithms and natural language processing

• Advanced materials: second in advanced composites and smart materials

• Energy: second in biofuels, third in supercapacitors, fourth in hydrogen and nuclear

In biofuels research specifically, ASPI notes that India "seems poised to overtake China in its publication rate within the next few years." If that happens, it would mark the only technology in the tracker where the lead country is neither the US nor China.

The Paradox

How do we reconcile two seemingly contradictory facts?

One, India's R&D spending as a share of GDP is among the lowest of any major economy, has barely moved in two decades, and is dominated by government rather than private investment.

Two, India's high-impact research output is growing faster than almost any other country's, and it now ranks in the top five globally in most critical technologies.

The answer lies in understanding what each metric captures — and what it misses.

R&D spending (GERD) measures inputs. The Critical Technology Tracker measures one specific output: frontier research. India appears to be getting an unusually high return on its research investment, at least as measured by citations and publications.

There are several possible explanations. India has a large pool of trained scientists and engineers whose labour costs are lower than in developed economies. Indian institutions have become better integrated into global research networks, with collaborations that boost citation counts. And India's sheer scale — the number of researchers, universities, and publications — creates volume that can translate into impact.

But here's the catch: research output is not the same as technological capability.

The Gap That Matters

The Economic Survey itself acknowledges this distinction, even if it doesn't connect it to the ASPI data. In Box VIII.6, it reproduces India's rankings from the Critical Technology Tracker — but adds a crucial caveat:

"Note: ASPI's rankings are research-output based and indicate relative scientific leadership and do not necessarily capture industrial maturity, commercial deployment, or production capabilities."

This is the gap that the Survey — and Indian policy — is most worried about.

India excels at Technology Readiness Levels 1-3: basic research, concept validation, proof of principle. It also has pockets of strength at TRL 7-9: commercialisation and deployment, particularly in sectors like IT services, pharmaceuticals, and space.

What's missing is the middle: TRL 4-6 — prototype development, system testing, piloting at scale. This is where research gets translated into products, where scientific leadership becomes industrial capability.

The Survey calls this the "valley of death" for Indian innovation. It's why India can rank second globally in biological manufacturing research but still import most of its medical devices. It's why India can be a leader in AI algorithm research but struggle to deploy AI at scale in manufacturing or agriculture.

Two Stories, One Reality

The pessimistic story about Indian R&D is not wrong. Private sector investment is low. GERD has stagnated. The translation gap is real. The Survey's critique of Indian industry — that it prefers rent-seeking to capability-building — is accurate.

But the optimistic story is also not wrong. India's research base is expanding rapidly. Its scientists are producing work that the global research community considers important. It is building the knowledge stock that could, with the right institutional and industrial support, become the foundation for technological sovereignty.

The question is whether India can connect these two realities.

The government's answer is a suite of new institutions and funding mechanisms: the Anusandhan National Research Foundation (ANRF), the Rs 1 lakh crore RDI Fund, mission-mode programmes in semiconductors, quantum, and green hydrogen. These are designed to bridge the valley — to pull research through to deployment.

But as the Survey itself notes, public investment cannot substitute for private capability. If Indian firms continue to prefer technology licensing and import over R&D, if they continue to seek protection rather than build competitiveness, then even a strong research base will not translate into industrial strength.

What the Data Demands

The ASPI data should change the conversation about Indian science and technology — but not in the way triumphalists might hope.

It shows that India is not starting from zero. It has research strengths across critical domains. It has scientific talent that produces globally recognised work. This is an asset — one that has been built over decades of public investment in universities, national labs, and research councils.

But assets must be deployed. The challenge is not producing more papers. It is building the institutions — Translational Research Centres, industry-academia linkages, patient capital for deep tech — that turn papers into prototypes, and prototypes into products.

The Survey gestures at this when it proposes TRCs as "shared national assets for piloting and prototyping." But it offers little detail on how these would work, who would fund them, or how they would be governed.

Meanwhile, China — which leads in 66 of 74 technologies in the ASPI tracker — is not just publishing papers. It is building fabs, deploying AI at scale, dominating battery supply chains, and manufacturing the hardware that powers the global economy. Research leadership has translated into industrial capability, which has translated into geopolitical leverage.

India's research rise is real. But research alone does not make a technology power. The next phase — the harder phase — is turning scientific strength into strategic capability.

That will require more than just funding. It will need an environment where Indian firms see R&D as a source of competitive advantage rather than a cost to be avoided, and where the state provides not just subsidies but discipline.

Also Read: The Economic Survey’s Uncomfortable Verdict On Indian Industry